SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Zheng T, Mayne ST, Boyle P, Holford TR, Liu WL, Flannery J. Epidemiology of non-Hodgkin lymphoma in Connecticut: 1935–1988. Cancer 1992; 70: 8409.
  • 2
    Cooper KD, Oberhelman L, Hamilton TA, Baadsgaard O, Terhune M, LeVee G, Anderson T, Koren H. UV exposure reduces immunization rates and promotes tolerance to epicutaneous antigens in humans: relationship to dose, CD1a-DR+ epidermal macrophage induction, and Langerhans cell depletion. Proc Natl Acad Sci USA 1992; 89: 8497501.
  • 3
    Kripke ML. Ultraviolet radiation and immunology: something new under the sun—presidential address. Cancer Res 1994; 54: 61025.
  • 4
    Kinlen L. Immunosuppressive therapy and acquired immunological disorders. Cancer Res 1992; 52: 5474S6S.
  • 5
    Opelz G, Henderson R. Incidence of non-Hodgkin lymphoma in kidney and heart transplant recipients. Lancet 1993; 342: 15146.
  • 6
    Birkeland SA, Storm HH, Lamm LU, Barlow L, Blohme I, Forsberg B, Eklund B, Fjeldborg O, Friedberg M, Frodin L. Cancer risk after renal transplantation in the Nordic countries, 1964–1986. Int J Cancer 1995; 60: 1839.
  • 7
    Cartwright RA, McNally R, Staines A. The increasing incidence of non-Hodgkin's lymphoma (NHL): the possible role of sunlight. Leuk Lymphoma 1994; 14: 38794.
  • 8
    Bentham G. Association between incidence of non-Hodgkin's lymphoma and solar ultraviolet radiation in England and Wales. Br Med J 1996; 312: 112831.
  • 9
    McMichael AJ, Giles GG. Have increases in solar ultraviolet exposure contributed to the rise in incidence of non-Hodgkin's lymphoma? Br J Cancer 1996; 73: 94550.
  • 10
    IARC. Solar and ultraviolet radiation. Lyon: IARC, 1992.
  • 11
    Frisch M, Melbye M. New primary cancers after squamous cell skin cancer. Am J Epidemiol 1995; 141: 91622.
  • 12
    Adami J, Frisch M, Yuen J, Glimelius B, Melbye M. Evidence of an association between non-Hodgkin's lymphoma and skin cancer. Br Med J 1995; 310: 14915.
  • 13
    Hall P, Rosendahl I, Mattsson A, Einhorn S. Non-Hodgkin's lymphoma and skin malignancies: shared etiology? Int J Cancer 1995; 62: 51922.
  • 14
    Levi F, Randimbison L, Te VC, La Vecchia C. Non-Hodgkin's lymphomas, chronic lymphocytic leukaemias and skin cancers. Br J Cancer 1996; 74: 184750.
  • 15
    ParkinDM, WhelanSL, FerlayJ, RaymondL, YoungJ, eds. Cancer incidence in five continents. Lyon: IARC, 1997.
  • 16
    JaffeES, HarrisNL, SteinH, VardimanJW, eds. Pathology and genetics of tumours of haematopoietic and lymphoid tissues: world health organization classification of tumours. Lyon: IARC, 2001.
  • 17
    National Centre in HIV Epidemiology and Clinical Research. HIV/AIDS, viral hepatitis and sexually transmissible infections in Australia annual surveillance report 2002. Sydney: National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, 2002.
  • 18
    Kricker A, Armstrong BK, English DR, Heenan PJ. Pigmentary and cutaneous risk factors for non-melanocytic skin cancer: a case-control study. Int J Cancer 1991; 48: 65062.
  • 19
    Dubin N, Moseson M, Pasternack BS. Epidemiology of malignant melanoma: pigmentary traits, ultraviolet radiation, and the identification of high-risk populations. Recent Results Cancer Res 1986; 102: 5675.
  • 20
    Australian Bureau of Statistics. Socio-economic indexes for areas, Australia. Canberra: Australian Bureau of Statistics, 1998.
  • 21
    Department of Primary Industries and Energy and Department of Human Services and Health. Rural, remote and metropolitan areas classification: 1991 census edition. Canberra: Australian Government Publishing Service, 1994.
  • 22
    Tracey EA, Supramaniam R. Cancer in New South Wales: incidence and mortality 2000. Sydney: Cancer Council New South Wales, 2002.
  • 23
    Bliss JM, Ford D, Swerdlow AJ, Armstrong BK, Cristofolini M, Elwood JM, Green A, Holly EA, Mack T, MacKie RM. Risk of cutaneous melanoma associated with pigmentation characteristics and freckling: systematic overview of 10 case-control studies—the International Melanoma Analysis Group (IMAGE). Int J Cancer 1995; 62: 36776.
  • 24
    Armstrong BK, Kricker A. The epidemiology of UV induced skin cancer. J Photochem Photobiol B 2001; 63: 818.
  • 25
    Woods JS, Polissar L, Severson RK, Heuser LS, Kulander BG. Soft tissue sarcoma and non-Hodgkin's lymphoma in relation to phenoxyherbicide and chlorinated phenol exposure in western Washington. J Natl Cancer Inst 1987; 78: 899910.
  • 26
    Green AC, O'Rourke MG. Cutaneous malignant melanoma in association with other skin cancers. J Natl Cancer Inst 1985; 74: 97780.
  • 27
    Holman CD, Armstrong BK. Cutaneous malignant melanoma and indicators of total accumulated exposure to the sun: an analysis separating histogenetic types. J Natl Cancer Inst 1984; 73: 7582.
  • 28
    Holly EA, Kelly JW, Shpall SN, Chiu SH. Number of melanocytic nevi as a major risk factor for malignant melanoma. J Am Acad Dermatol 1987; 17: 45968.
  • 29
    Bennett MH, MacLennan KA, Hudson GV, Hudson BV. Non-Hodgkin's lymphoma arising in patients treated for Hodgkin's disease in the BNLI: a 20-year experience—British National Lymphoma Investigation. Ann Oncol 1991; 2: 8392.
  • 30
    Swerdlow AJ, Barber JA, Hudson GV, Cunningham D, Gupta RK, Hancock BW, Horwich A, Lister TA, Linch DC. Risk of second malignancy after Hodgkin's disease in a collaborative British cohort: the relation to age at treatment. J Clin Oncol 2000; 18: 498509.
  • 31
    Abrahamsen AF, Andersen A, Nome O, Jacobsen AB, Holte H, Abrahamsen JF, Kvaloy S. Long-term risk of second malignancy after treatment of Hodgkin's disease: the influence of treatment, age and follow-up time. Ann Oncol 2002; 13: 178691.
  • 32
    Mauch PM, Kalish LA, Marcus KC, Coleman CN, Shulman LN, Krill E, Come S, Silver B, Canellos GP, Tarbell NJ. Second malignancies after treatment for laparotomy staged IA-IIIB Hodgkin's disease: long-term analysis of risk factors and outcome. Blood 1996; 87: 362532.
  • 33
    Abrahamsen JF, Andersen A, Hannisdal E, Nome O, Abrahamsen AF, Kvaloy S, Host H. Second malignancies after treatment of Hodgkin's disease: the influence of treatment, follow-up time, and age. J Clin Oncol 1993; 11: 25561.
  • 34
    van Leeuwen FE, Chorus AM, van den Belt-Dusebout AW, Hagenbeek A, Noyon R, van Kerkhoff EH, Pinedo HM, Somers R. Leukaemia risk following Hodgkin's disease: relation to cumulative dose of alkylating agents, treatment with teniposide combinations, number of episodes of chemotherapy, and bone marrow damage. J Clin Oncol 1994; 12: 106373.
  • 35
    Ng A, Bernardo MV, Weller E, Backstrand K, Silver B, Marcus KC, Tarbell NJ, Stevenson MA, Friedberg JW, Mauch PM. Second malignancy after Hodgkin disease treated with radiation therapy with or without chemotherapy: long-term risks and risk factors. Blood 2002; 100: 198996.
  • 36
    Preston DL, Kusumi S, Tomonaga M, Izumi S, Ron E, Kuramoto A, Kamada N, Dohy H, Matsuo T. Cancer incidence in atomic bomb survivors. Part III. Leukemia, lymphoma and multiple myeloma, 1950–1987. Radiat Res 1994; 137(Suppl 2): S6897.
  • 37
    United Nations Scientific Committee on the Effects of Atomic Radiation. Ionizing radiation: sources and biological effects—2000 report to the general assembly, with annexes. New York: United Nations, 2000.
  • 38
    McLaughlin JK, Hrubec Z, Blot WJ, Fraumeni JF Jr. Smoking and cancer mortality among US veterans: a 26-year follow-up. Int J Cancer 1995; 60: 1903.
  • 39
    Adami J, Nyren O, Bergstrom R, Ekbom A, Engholm G, Englund A, Glimelius B. Smoking and the risk of leukemia, lymphoma, and multiple myeloma (Sweden). Cancer Causes Control 1998; 9: 4956.
  • 40
    Herrinton LJ, Friedman GD. Cigarette smoking and risk of non-Hodgkin's lymphoma subtypes. Cancer Epidemiol Biomarkers Prev 1998; 7: 258.
  • 41
    Parker AS, Cerhan JR, Dick F, Kemp J, Habermann TM, Wallace RB, Sellers TA, Folsom AR. Smoking and risk of non-Hodgkin lymphoma subtypes in a cohort of older women. Leuk Lymphoma 2000; 37: 3419.
  • 42
    Williams RR, Horm JW. Association of cancer sites with tobacco and alcohol consumption and socioeconomic status of patients: interview study from the Third National Cancer Survey. J Natl Cancer Inst 1977; 58: 5247.
  • 43
    Hoar SK, Blair A, Holmes FF, Boysen CD, Robel RJ, Hoover R, Fraumeni JF Jr. Agricultural herbicide use and risk of lymphoma and soft-tissue sarcoma. JAMA 1986; 256: 11417.
  • 44
    Nelson RA, Levine AM, Marks G, Bernstein L. Alcohol, tobacco and recreational drug use and the risk of non-Hodgkin's lymphoma. Br J Cancer 1997; 76: 15327.
  • 45
    Holly EA, Lele C, Bracci P, McGrath MS. Case-control study of non-Hodgkin's lymphoma among women and heterosexual men in the San Francisco Bay Area, California. Am J Epidemiol 1999; 150: 37590.
  • 46
    Schroeder JC, Olshan AF, Dent RB, Weinberg CR, Yount B, Cerhan JR, Lynch CF, Schuman LM, Tolbert PE, Rothman N, Cantor KP, Blair A. A case-control study of tobacco use and other non-occupational risk factors for t(14;18) subtypes of non-Hodgkin's lymphoma (United States). Cancer Causes Control 2002; 13: 15968.
  • 47
    Stagnaro E, Ramazzotti V, Crosignani P, Fontana A, Masala G, Miligi L, Nanni O, Neri M, Rodella S, Costantini AS, Tumino R, Vigano C, et al. Smoking and hematolymphopoietic malignancies. Cancer Causes Control 2001; 12: 32534.
  • 48
    Peach HG, Barnett NE. Critical review of epidemiological studies of the association between smoking and non-Hodgkin's lymphoma. Hematol Oncol 2001; 19: 6780.